Galera Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$59,082,000 over the previous period. Total operating expenses were $46,951,000.
Profit Margin
| 2017 | 0 | -23.54M | |
|---|---|---|---|
| 2018 | 0 | -23.67M | |
| 2019 | 0 | -51.93M | |
| 2020 | 0 | -74.21M | |
| 2021 | 0 | -87.72M | |
| 2022 | 0 | -62.22M | |
| 2023 | 0 | -59.08M |
GRTX Income Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 259K | 114K | 778K | 368K | 267K | 0 | 84K |
Gross profit | -259K | -114K | -778K | -368K | -267K | 0 | -84K |
Operating exp. | |||||||
Research and development | 24.11M | 31.01M | 52.41M | 54.84M | 42.33M | 18.66M | 20.59M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 46.95M | 51.22M | 73.36M | 70.55M | 50.69M | 24.25M | 24.09M |
Operating income | -46.95M | -51.22M | -73.36M | -70.55M | -50.69M | -24.25M | -24.09M |
Other income (expenses), net | -12.13M | -11.06M | -7.16M | -3.68M | -1.24M | -30K | 189K |
Income before tax | -59.08M | -62.29M | -80.53M | -74.23M | -51.93M | -23.89M | -23.90M |
Income tax expense | 0 | -70K | 7.19M | -16K | -9K | -223K | -360K |
Net income | -59.08M | -62.22M | -87.72M | -74.21M | -51.93M | -23.67M | -23.54M |
Earnings per share | |||||||
Basic EPS | -1.33 | -2.3 | -3.4 | -2.98 | -2.09 | -1.22 | -1.55 |
Diluted EPS | -1.33 | -2.3 | -3.4 | -2.98 | -2.09 | -1.22 | -1.55 |
| Data source | Data source | Data source | Data source | Data source |